Número de publicaciones
126
Buscador de publicaciones
  • Fernández O; Montalban X; Agüera E; Aladro Y; Alonso A; Arroyo R; Brieva L; Calles C; Costa-Frossard L; Eichau S; García-Domínguez JM; Hernández MA; Landete L; Llaneza M; Llufriu S; Meca-Lallana JE; Meca-Lallana V; Mongay-Ochoa N; Moral E; Oreja-Guevara C; Ramió-Torrentà L; Téllez N; Romero-Pinel L; Rodríguez-Antigüedad A

    XV Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2022 (II).

    REVISTA DE NEUROLOGIA 77 47-60. .

    [doi:10.33588/rn.7702.2023168]

  • Fernández, O; Montalban, X; Agüera, E; Aladro, Y; Alonso, A; Arroyo, R; Brieva, L; Calles, C; Costa-Frossard, L; Eichau, S; García-Domínguez, JM; Hernández, MA; Landete, L; Llufriu, MLS; Meca-Lallana, JE; Meca-Lallana, V; Mongay-Ochoa, N; Moral, E; Oreja-Guevara, C; Ramió-Torrentà, L; Téllez, N; Romero-Pinel, L; Rodríguez-Antigüedad, A

    15th Post-ECTRIMS Meeting: a review of the latest developments presented at the 2022 ECTRIMS Congress (Part I)

    REVISTA DE NEUROLOGIA 77 19-30. .

    [doi:10.33588/rn.7701.2023167]

  • Vicente-Pascual, M; Quilez, A; Gil, MP; Gonzalez-Mingot, C; Vazquez-Justes, D; Mauri-Capdevila, G; Sanahuja, J; Garcia-Vazquez, C; Purroy, F

    The influence of organisational management on door-to-needle times for fibrinolytic treatment

    NEUROLOGIA 38 313-318. .

    [doi:10.1016/j.nrl.2020.10.014]

  • González-Mingot, C; Miana-Mena, FJ; Iñarrea, PJ; Iñiguez, C; Capablo, JL; Osta, R; Gil-Sánchez, A; Brieva, L; Larrodé, P

    Mitochondrial Aconitase Enzymatic Activity: A Potential Long-Term Survival Biomarker in the Blood of ALS Patients

    Journal of Clinical Medicine 12 -. .

    [doi:10.3390/jcm12103560]

  • Torres P; Sancho-Saldaña A; Gil Sánchez A; Peralta S; Solana MJ; Bakkioui S; González-Mingot C; Quibus L; Ruiz-Fernández E; San Pedro-Murillo E; Brieva L

    A prospective study of cellular immune response to booster COVID-19 vaccination in multiple sclerosis patients treated with a broad spectrum of disease-modifying therapies.

    JOURNAL OF NEUROLOGY 270 1-12. .

    [doi:10.1007/s00415-023-11575-8]

  • Gil-Sanchez A; Canudes M; Valcheva P; Nogueras L; González-Mingot C; Hervás JV; Peralta S; Solana MJ; Brieva L

    Effects of vortioxetine on cognition and fatigue in patients with multiple sclerosis and depression: a case series study.

    CNS & Neurological Disorders-Drug Targets 23 395-401. .

    [doi:10.2174/1871527322666230321093133]

  • Lleixà C; Caballero-Ávila M; Pascual-Goñi E; Martín-Aguilar L; Vidal N; Tejada C; Valdés-Hevia E; Zárate E; Vesperinas A; Collet R; Franco-Leyva T; Martínez-Martínez L; Moga E; Cortés-Vicente E; Rojas-García R; Gómez-Anson B; Gil A; González-Mingot C; Brieva L; Martínez-Yélamos S; Querol L

    Antibodies against the flotillin-1/2 complex in patients with multiple sclerosis.

    Brain Communications 5 -. .

    [doi:10.1093/braincomms/fcad109]

  • de la Maza, SS; Gómez-Ballesteros, R; Borges, M; Martín-Martínez, J; Sotoca, J; Alonso, A; Caminero, AB; Borrega, L; Sánchez-Menoyo, JL; Barrero-Hernández, FJ; Calles, C; Brieva, L; Blasco-Quílez, MR; García-Soto, JD; del Campo-Amigo, M; Navarro-Cantó, L; Agüera, E; Garcés-Redondo, M; Carmona, O; Gabaldón-Torres, L; Forero, L; Hervàs, M; Medrano, N; Maurino, J; Castillo-Triviño, T

    Detecting disability using self-reported and clinical assessments in early-stage relapsing-remitting multiple sclerosis: Looking for a complementary approach

    Multiple Sclerosis Journal-Experimental Translational And Clinical 9 -. .

    [doi:10.1177/20552173231169475]

  • Monreal, E; Fernandez-Velasco, JI; Garcia-Sanchez, MI; Sainz de la Maza S; Llufriu, S; Alvarez-Lafuente, R; Casanova, B; Comabella, M; Ramio-Torrenta, L; Martinez-Rodriguez, JE; Brieva, L; Saiz, A; Eichau, S; Cabrera-Maqueda, JM; Villarrubia, N; Espiño M; Perez-Miralles, F; Montalban, X; Tintore, M; Quiroga-Varela, A; Dominguez-Mozo, MI; Rodriguez-Jorge, F; Chico-Garcia, JL; Lourido, D; Alvarez-Cermeno, JC; Masjuan, J; Costa-Frossard, L; Villar, LM

    Association of Serum Neurofilament Light Chain Levels at Disease Onset With Disability Worsening in Patients With a First Demyelinating Multiple Sclerosis Event Not Treated With High-Efficacy Drugs.

    JAMA Neurology 80 397-403. .

    [doi:10.1001/jamaneurol.2023.0010]

  • Río J.; Peña J.; Brieva L.; García-Domínguez J.M.; Rodríguez-Antigüedad A.; Oreja-Guevara C.; Costa-Frossard L.; Arroyo R.

    Monitoring response to disease-modifying treatment in multiple sclerosis

    Neurology Perspectives 3 -. .

    [doi:10.1016/j.neurop.2023.100119]

  • de la Maza, SS; Maurino, J; Castillo-Triviño, T; Borges, M; Torres, BS; Sotoca, J; Torres, AMA; Caminero, AB; Borrega, L; Sánchez-Menoyo, JL; Barrero-Hernández, FJ; Calles, C; Brieva, L; Blasco, MR; García-Soto, JD; Rodríguez-Regal, A; Navarro-Cantó, L; Agüera-Morales, E; Garcés, M; Carmona, O; Gabaldón-Torres, L; Forero, L; Hervás, M; Gómez-Ballesteros, R

    Hopelessness in Patients with Early-Stage Relapsing-Remitting Multiple Sclerosis

    Patient Preference And Adherence 17 1431-1439. .

    [doi:10.2147/PPA.S411069]

  • Higueras Y; Borges M; Jiménez-Martín I; Conde C; Aparicio-Mingueza A; Sierra-Martínez E; Gich-Fulla J; Balaguer-Marmaña M; Gil-Sánchez A; Anglada E; Jover A; Pérez-Martín MY; Arévalo MJ; Arrabal-Gómez C; Jiménez-Veiga J; Lubrini G; Molano A; García-Vaz F

    Cognitive assessment in patients with multiple sclerosis: A Spanish consensus.

    Frontiers In Rehabilitation Sciences 3 1006699-1006699. .

    [doi:10.3389/fresc.2022.1006699]